Treatment of carcinoma of the breast with high dose oral medroxyprogesterone acetate: does increased bioavailability improve the therapeutic ratio?

Roberts, J T; Bates, T; Bozzino, J M; Brock, J E; Clarke, D G; Durrant, K R; Evans, R G; Tobias, J S

Roberts, J T; Bates, T; Bozzino, J M; Brock, J E; Clarke, D G; Durrant, K R; Evans, R G; Tobias, J S.

Affiliation

Roberts JT; Department of Radiotherapy, Newcastle General Hospital, Newcastle-upon-Tyne.

Clin Oncol (R Coll Radiol) ; 2(6): 324-7, 1990 Nov.

Article in En | MEDLINE | ID: mdl-2149061

Subject(s)

Antineoplastic Agents/administration & dosage; Breast Neoplasms/drug therapy; Medroxyprogesterone/analogs & derivatives; Administration, Oral; Adult; Aged; Antineoplastic Agents/pharmacokinetics; Biological Availability; Female; Humans; Medroxyprogesterone/administration & dosage; Medroxyprogesterone/adverse effects; Medroxyprogesterone/pharmacokinetics; Medroxyprogesterone Acetate; Middle Aged; Pilot Projects

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Medroxyprogesterone / Antineoplastic Agents Limits: Adult / Aged / Female / Humans / Middle aged Language: En Journal: Clin Oncol (R Coll Radiol) Journal subject: NEOPLASIAS Year: 1990 Type: Article

Search on Google

XML

PubMed Links